Personal information

No personal information available

Activities

Employment (5)

Leiden University Medical Center: Leiden, NL

2022-12 to present | Medical resident (Clinical genetics)
Employment
Source: Self-asserted source
Ivo Pieter van de Peppel

Erasmus MC: Rotterdam, NL

2022 to 2022 | Medical doctor (Clinical genetics)
Employment
Source: Self-asserted source
Ivo Pieter van de Peppel

University Medical Center Groningen: Groningen, Groningen, NL

2019 to 2022 | Post-doctoral researcher (Pediatrics )
Employment
Source: Self-asserted source
Ivo Pieter van de Peppel

University Medical Center Groningen: Groningen, Groningen, NL

2016 to 2019 | MD-PhD student (Pediatrics)
Employment
Source: Self-asserted source
Ivo Pieter van de Peppel

Emory University: Atlanta, GA, US

2018 to 2018 | PhD student (Pediatrics)
Employment
Source: Self-asserted source
Ivo Pieter van de Peppel

Works (10)

Atypical Progeria Primarily Manifesting as Premature Cardiac Valvular Disease Segregates with <i>LMNA</i>-Gene Variants

Journal of Cardiovascular Development and Disease
2024-03 | Journal article | Author
Contributors: Hoi Wai Wu; Ivo Pieter van de Peppel; Julie W. Rutten; J. Wouter Jukema; E Aten; Ingrid M. Jazet; Tamara Koopmann; Daniela Barge-Schaapveld; Nina Ajmone Marsan
Source: check_circle
Multidisciplinary Digital Publishing Institute

Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis.

Hepatology (Baltimore, Md.)
2020-07-23 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats.

Pediatric research
2020-05-01 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.

Frontiers in medicine
2020-02-25 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.

Expert opinion on investigational drugs
2020-01-03 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice.

Journal of lipid research
2019-07-19 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.

American journal of physiology. Gastrointestinal and liver physiology
2019-01-17 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2018-09-29 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2018-09-07 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel

Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.

Current opinion in pulmonary medicine
2017-11-01 | Journal article
Source: Self-asserted source
Ivo Pieter van de Peppel